» Articles » PMID: 36647218

The Impact of Omicron Wave on Pediatric Febrile Seizure

Overview
Specialty General Medicine
Date 2023 Jan 17
PMID 36647218
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The coronavirus disease 2019 (COVID-19) omicron (B.1.1.529) variant reduced the risk of severe disease compared with the original strain and other variants, but it appeared to be highly infectious, which resulted in an exponential increase in confirmed cases in South Korea. As the number of confirmed cases increased, so did the number of pediatric patients' hospitalization. This study aims to evaluate the frequency and clinical features of febrile seizure associated with the COVID-19 omicron variant in children.

Methods: We retrospectively reviewed the medical records of children aged under 18 years with febrile seizure who were tested for COVID-19 from February 2020 to April 2022 at Ajou University Hospital, South Korea. Based on the dominant variants, we divided the period into the pre-omicron (from February 2020 to December 2021) and omicron periods (from January 2022 to April 2022) and compared the clinical characteristics between the two. Also, we compared the clinical characteristics of febrile seizure between COVID-19 positive and negative group during the omicron period.

Results: Among the 308 children, 211 patients (9.2 patients/months) and 97 patients (24.3 patients/months) were grouped into pre-omicron and omicron periods, respectively. Compared with the pre-omicron period, patients in the omicron period showed significantly higher mean age (pre-omicron vs. omicron, 22.0 vs. 28.0 months; = 0.004) and COVID-19 positive results (pre-omicron vs. omicron, 0.5% vs. 62.9%; < 0.001). As the COVID-19 confirmed cases in the omicron period increased, the number of COVID-19 associated febrile seizure also increased. In the omicron period, 61 children were confirmed to be positive for COVID-19, and COVID-19 positive group showed statistically significant higher mean age (positive vs. negative, 33.0 vs. 23.0 months; = 0.003) and peak body temperature than the negative group (positive vs. negative, 39.1°C vs. 38.6°C; = 0.030). Despite the lack of significance, COVID-19 positive group showed longer seizure time, multiple seizure episodes, and higher prevalence of complex febrile seizure.

Conclusion: The frequency of COVID-19 associated febrile seizure increased in the omicron periods. In addition, in this period, children with febrile seizure diagnosed with COVID-19 had a higher mean age and higher peak body temperature.

Citing Articles

Clinical and hematological characteristics of children infected with the omicron variant of SARS-CoV-2: role of the combination of the neutrophil: lymphocyte ratio and eosinophil count in distinguishing severe COVID-19.

Jin Q, Ma W, Zhang W, Wang H, Geng Y, Geng Y Front Pediatr. 2024; 12:1305639.

PMID: 38978839 PMC: 11228319. DOI: 10.3389/fped.2024.1305639.


Specific convulsions and brain damage in children hospitalized for Omicron BA.5 infection: an observational study using two cohorts.

Pei Y, Wang H, Yin G, Xu Y, Tan J, Liang X World J Pediatr. 2024; 20(10):1079-1089.

PMID: 38713366 PMC: 11502579. DOI: 10.1007/s12519-024-00808-z.


Has the Incidence of Febrile Convulsions in Childhood Changed During the SARS-CoV-2 Pandemic?.

Kovacs M, Makszin L, Nyul Z, Hollody K J Child Neurol. 2024; 39(5-6):190-194.

PMID: 38698642 PMC: 11179305. DOI: 10.1177/08830738241249630.


Seizures in febrile children with SARS-CoV-2 infection: clinical features, short-term follow-up.

Jiang J, Shen Z, Cao J BMC Pediatr. 2024; 24(1):257.

PMID: 38627666 PMC: 11022318. DOI: 10.1186/s12887-024-04691-5.


Decreased NK cell count is a high-risk factor for convulsion in children with COVID-19.

Shi T, Bian Y, Wu J, Li X, Deng J, Feng T BMC Infect Dis. 2023; 23(1):856.

PMID: 38057734 PMC: 10698890. DOI: 10.1186/s12879-023-08556-7.


References
1.
Chiu T, Leung W, Zhang Q, Lau E, Ho R, Chan H . Changes in pediatric seizure-related emergency department attendances during COVID-19 - A territory-wide observational study. J Formos Med Assoc. 2020; 120(8):1647-1651. PMC: 7680012. DOI: 10.1016/j.jfma.2020.11.006. View

2.
Christy A . COVID-19: A Review for the Pediatric Neurologist. J Child Neurol. 2020; 35(13):934-939. DOI: 10.1177/0883073820939387. View

3.
Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

4.
Esmaili Gourabi H, Bidabadi E, Cheraghalipour F, Aarabi Y, Salamat F . Febrile seizure: demographic features and causative factors. Iran J Child Neurol. 2014; 6(4):33-7. PMC: 3943022. View

5.
Sawires R, Buttery J, Fahey M . A Review of Febrile Seizures: Recent Advances in Understanding of Febrile Seizure Pathophysiology and Commonly Implicated Viral Triggers. Front Pediatr. 2022; 9:801321. PMC: 8793886. DOI: 10.3389/fped.2021.801321. View